Sign in

CIK 0001035354

  • Non-accelerated filer
  • Smaller reporting company

Eloxx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELOX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
841368850
Phone
+1 781-577-5300
Business address
P.O. BOX 274, ARLINGTON, MA, 02476
Former names
Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
  1. 4 Open-market buy Director bought 882,381 shares
  2. 4 Open-market buy Director bought 16,745 shares
  3. 4 Open-market sale Former President & CEO sold 49,500 shares at an average $0.38 ($18,770)
  4. 4 Returned to the company Former President & CEO returned 141,500 shares (to the company)
  5. 4 Returned to the company CFO and Treasurer returned 10,000 shares (to the company)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Returned to the company CFO and Treasurer returned 1,400 shares (to the company)
  16. 4 Returned to the company VP - Corporate Dev. returned 2,100 shares (to the company)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market buy Director bought 6,250 shares at $0.90 ($2,000)
  19. 4 Open-market buy Director bought 275,000 shares at $0.90 ($88,000)
  20. 4 Open-market buy Director bought 6,250 shares at $0.90 ($2,000)

Page 21 of 29 · 574 filings